While U.S. regulators are pushing for more transparency and audit quality of Chinese firms listing on U.S. stock exchanges, some plaintiffs firms still see high risks for investors.
In the second part of this series, Ivan Jin, Allen Liu, Bella Cao and Huppert Hu of Merits & Tree Law Offices look at the ever-expanding opportunities for cooperation between insurance companies and foreign investors amidst a complex regulatory landscape
CSRC plans to exempt foreign investors from short-term profit rules; Foshan Government vastly increases financial support for overseas IP protection; BNP Paribas gains regulatory approval from CBIRC for wealth management joint venture with Agricultural Bank of China.
In the first part of a two-part series, Ivan Jin, Allen Liu, Bella Cao and Huppert Hu of Merits & Tree Law Offices explain how foreign capital and Chinese insurance funds can aim to "dance with harmony" in China's private equity market, as they navigate multiple regulatory and practical challenges
As the relationship between the U.S. and China has deteriorated, an increasing number of Chinese companies are ending their U.S.-based operations. Derek Liu, Rod Hunter and Howard Wu of Baker McKenzie set out some guidance for those heading down that path
The U.S. Department of Defense imposes further sanctions on Chinese tech firms; Chinese chip companies denied access to U.S. technologies; Tim Hortons China secures a SPAC merger.
Four Chinese companies have listed on the Swiss Exchange in recent months and a host of law firms have benefited. More such IPOs are in the pipeline, but will interest in European listings last?
